Mendor, a leading company in new diabetes technologies and services, announces € 8.1 Million of Venture Capital financing to facilitate its global market expansion. The series-B financing round was led by the Finnish entrepreneur and investor Risto Siilasmaa, joined by Life Sciences Partners (LSP), Finnish Industry Investment Ltd., Finnish Mutual Pension Insurance Company Ilmarinen, private Finnish investment group Biothom and the Finnvera Venture Capital as a returning investor.
Read more: http://www.mendor.com
Mendor was recently selected as a Red Herring Europe top 100 technology start-up.
Read more: http://www.mendor.com/Press.aspx